(Q45231099)

11 December 2017

title

Comparison of the effects of intrapericardial and intravenous aldosterone infusions on left ventricular fibrosis in rats (English)

1 reference

11 December 2017

author name string

Monica Minnaard-Huiban

1

1 reference

11 December 2017

J J Rob Hermans

2

1 reference

11 December 2017

Helma van Essen

3

1 reference

11 December 2017

Nicole Bitsch

4

1 reference

11 December 2017

Jos F M Smits

5

1 reference

11 December 2017

publication date

11 November 2008

1 reference

European Journal of Heart Failure

11 December 2017

published in

1 reference

11 December 2017

volume

10

1 reference

11 December 2017

issue

12

1 reference

11 December 2017

page(s)

1166-1171

1 reference

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Molecular mechanisms of myocardial remodeling. The role of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Mineralocorticoid receptors and glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Induction of cardiac fibrosis by aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Detection of corticosteroid type I binding sites in heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Why are mineralocorticoid receptor antagonists cardioprotective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Pharmacokinetic advantage of intrapericardially applied substances in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Intrapericardial delivery enhances cardiac effects of sotalol and atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.09.012

10.1016/J.EJHEART.2008.09.012

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference